-
Innovation Ranking
NewInnovation Ranking – Aehr Test Systems
Aehr Test Systems (Aehr Test) is a provider of test systems for burning-in and testing memory and logic integrated circuits. The company develops, manufactures and sells systems which are designed to perform reliability screening, or burn-in, of logic and memory devices, sensors and optical devices. It offers products which include FOX-1p high volume production test solution, advanced burn-in and test system for packaged parts, DiePak components, single touchdown full wafer contractors for FOX sytems, WaferPak a contactor and related products....
-
Innovation Ranking
NewInnovation Ranking – Centre Testing International Group Co Ltd
Centre Testing International Group Co Ltd (CTI), a provider of testing and verification services. The company is a third-party agency that specializes in calibration, testing, inspection, certification and technical services. It offers a one-stop solution to its client. CTI's major services include CTI-SET, audit services, inspection services, certification and also training, environmental services and services related to the product certification center. The company provides its services to various industries such as pharmaceuticals, cosmetics, automobiles, power, food and some others. It...
-
Sector Analysis
NewReproductive Hormones and Proteins Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Reproductive Hormones and Proteins Tests Market Report Overview The reproductive hormones and proteins tests market size was $119.1 million in 2023. The market is expected to grow at a CAGR of more than 1% during 2023-2033. Reproductive hormones and proteins assist in the control and regulation of physiological processes including metabolism, reproduction, and growth and development. They are secreted either from endocrine glands or from organs with secondary endocrine functions and affect the health and behavior of both males and...
-
Product Insights
NewCardiac Markers Rapid Tests and POC Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Cardiac Markers Rapid Tests and POC Pipeline Market Report Overview Cardiac markers rapid tests & point of care (POC) are simple to perform rapid diagnostic tests that are ready to use, accurate, economical, and for infield use. These tests are suggested for individuals suspected of any indication. The Cardiac Markers Rapid Tests and POC pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes...
-
Product Insights
NewHuman Immunodeficiency Virus (HIV) Tests Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
HIV Tests Pipeline Market Report Overview Human Immunodeficiency Virus (HIV) tests refer to the antigens, antibodies, and nucleic acid reagent tests performed for the detection of HIV type I. The HIV Tests pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated...
-
Sector Analysis
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests Market Report Overview The Chlamydia Trachomatis and Neisseria Gonorrhoeae Tests market size was $2.81 billion in 2023. The market will grow at a CAGR of less than 1% during 2023-2033. Chlamydia is a common sexually transmissible disease, caused by the bacteria Chlamydia Trachomatis. In women, Chlamydia Trachomatis infections are often asymptomatic. However, if left untreated they can cause pelvic inflammatory disease (PID), which, in turn, can lead to additional complications such as infertility, ectopic...
-
Sector Analysis
HER2 Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
HER2 tests Market Report Overview The HER2 tests market size was valued at $123.6 million in 2023. The HER2 tests market will grow at a CAGR of more than 1% from 2023 to 2033. HER2 Testing includes extracting a sample of tumor tissue in a procedure called biopsy, which may be either fine-needle aspiration biopsy, core needle or surgical biopsy. HER2 status can also be determined by next-generation sequencing and array comparative genomic hybridization (aCGH). HER2 tests Market Outlook 2023-2033...
-
Sector Analysis
Hemostasis Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Hemostasis Tests Market Report Overview The hemostasis tests market size was valued at $594.3 million in 2023. The hemostasis tests market will grow at a CAGR of more than 1% from 2023 to 2033. The increasing prevalence of surgical cases, rise in VTE incidence, and demand for point of care (POC) coagulation testing are driving factors for the growth of the hemostasis testing market. There is demand for POC tests for hemostasis tests due to the time-consuming process of laboratory-based...
-
Sector Analysis
BRCA Tests Market Size by Segments, Share, Regulatory, Reimbursement and Forecast to 2033
BRCA Tests Market Report Overview The BRCA Tests market size was $12.9 million in 2023. The market is expected to grow at a CAGR of more than 3% during 2023-2033. Breast cancer type 1 (BRCA1) and Breast cancer type 1 (BRCA1 gene tests, under the overall umbrella of BRCA Tests) are carried out to detect gene rearrangements within blood samples. The outcome of this may guide therapies and prophylactic actions to treat or prevent certain types of breast and ovarian...
-
Sector Analysis
Helicobacter Pylori Tests Market Size by Segments, Share, Regulatory, Reimbursement, and Forecast to 2033
Helicobacter Pylori Tests Market Report Overview The Helicobacter Pylori Tests market size was valued at $338.5 million in 2023. The Helicobacter Pylori Tests market will grow at a CAGR of more than 2% from 2023 to 2033. H. pylori has been recognized as a Class I carcinogen by the International Agency for Research on Cancer and as one of the strongest known risk factors for gastric malignancies such as peptic ulcer disease, gastric MALT lymphoma and gastric cancer as 89%...